Clinical Trial Update: Repeat Dose Safety Study for Compound to Treat Asthma [Phase 1]

View source ↗

Summary

A Phase 1 repeat-dose safety study for a compound intended to treat asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Accenture | Conditions: Asthma | Phase 1 | Status: COMPLETED